DRW Securities, LLC
Broker-DealerPosition in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1481986
CHICAGO, IL
Position in MDGL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$219,857
New position
Shares Held
420
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in MDGL
reported options exposure · as of Mar 31, 2026CallValue
$1,308,675
CallShares
2,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026DRW Securities, LLC holds $13,086,376 across 39 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CNTN |
Canton Strategic Holdings, Inc.
|
1,724,618 | $4,863,422 | |
| 2 | ARGX |
Argenx SE
|
947 | $878,598 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
1,731 | $493,283 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
|
17,111 | $432,908 | |
| 5 | SVRA |
Savara Inc
|
69,638 | $428,970 | |
| 6 | AUPH |
Aurinia Pharmaceuticals Inc.
|
22,294 | $378,329 | |
| 7 | IMNM |
Immunome Inc.
|
17,686 | $374,766 | |
| 8 | INCY |
Incyte Corp
|
3,100 | $351,416 |
All Filings in MDGL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $219,857 | 420 | Shares | Other | 2026-05-13 | |
| 2026-03-31 | $1,308,675 | 2,500 | Call | Other | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||